Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.
GENX stock price ended at $0 on 木曜日, after rising NaN%
On the latest trading day Apr 09, 2026, the stock price of GENX rose by NaN%, climbing from $0.00 to $0.00. Throughout the session, the stock experienced a volatility of NaN%, with prices fluctuating between a daily low of $0.00 and a high of $0.00. Alongside this price increase, trading volume also rose by 4.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 1.0K shares were traded, amounting to a market value of approximately --.
Comment les indicateurs d'analyse technique s'appliquent-ils à GENX ?
Selon l'analyse technique, Genex Pharmaceutical Inc a un signal agrégé de Neutral. Genex Pharmaceutical Inc a 0 signaux d'achat, 7 signaux neutres et 0 signaux de vente.
Quels sont les niveaux de retracement de Fibonacci pour GENX ?
Le niveau de retracement de Fibonacci de Genex Pharmaceutical Inc est 78.6%と100%の間。
Quel est le RSI de Genex Pharmaceutical Inc ?
Le RSI de Genex Pharmaceutical Inc est actuellement de NaN, indiquant une condition 中立
Quel est le prix de Genex Pharmaceutical Inc pour les 12 prochains mois ?
Le prix de Genex Pharmaceutical Inc GENX pour les 12 prochains mois est estimé à $0.
Jusqu'où Genex Pharmaceutical Inc est-il attendu?
Selon les analystes de Wall Street, Genex Pharmaceutical Inc devrait atteindre une prévision haute de $0.